KY02111 inhibits Wnt signaling and promotes the differentiation of hPSCs into cardiomyocytes, which may have an effect on the downstream of APC and GSK3β.

 

Brand: BCM

 

Target: Wnt/beta-catenin

 

Signaling Pathways: Cytoskeletal Signaling; Stem Cells

 

pKa: 9.92±0.70(Predicted)

 

Solubility: Soluble in DMSO. Insoluble in Water; insoluble in Ethanol.

 

GHS: GHS07

 

Isomeric SMILES: COC1=C(C=C(C=C1)CCC(=O)NC2=NC3=C(S2)C=C(C=C3)Cl)OC  

 

InChIKey: LXFKEVQQSKQXPR-UHFFFAOYSA-N  

 

InChI: InChI=1S/C18H17ClN2O3S/c1-23-14-7-3-11(9-15(14)24-2)4-8-17(22)21-18-20-13-6-5-12(19)10-16(13)25-18/h3,5-7,9-10H,4,8H2,1-2H3,(H,20,21,22) 

 

Attribute
[Chem Name]	N-(6-chloro-1,3-benzothiazol-2-yl)-3-(3,4-dimethoxyphenyl)propanamide
[Synonym]	KY02111; KY-02111; KY 02111
[CAS No.]	1118807-13-8
[EINECS]	808-505-5
[MDL No.]	MFCD08483062
[Formula]	C18H17ClN2O3S
[Molecular]	376.86
[Form]	White to beige powder
[Storage]	Sealed in dry, 2-8°C

Goods Tag